New Gpc Inc. Recalls Mustarcreme for Labeling and Listing Deficiencies
New Gpc Inc. is recalling Mustarcreme units in New York because the product lacks required drug listings, OTC labeling, and is marked not approved for U.S. sale.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves labeling and listing deficiencies rather than a direct physical hazard or reported illness, fitting the criteria for minor labeling errors or low-risk issues.
Plain-English summary
New Gpc Inc. has initiated a recall of Mustarcreme, a 60g (21 oz) over-the-counter drug product originating from Guyana. The recall involves 1,320 units distributed in New York. The affected batch numbers are 305150, 312236, and 311231.
The recall was issued because the product does not meet monograph requirements. Specifically, the product lacks a drug listing, fails to meet OTC drug labeling requirements, and is labeled as not approved for sale in the U.S.A.
Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- MUSTARCREME, Net Contents: 60g (21 oz) Country of Origin Guyana.
- Manufacturer
- New Gpc Inc.
- Category
- Drug — Over-the-Counter
- Affected units
- 1,320
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Batch Numbers: 305150
- 312236
- 311231
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 7 recalled by New Gpc Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · New Gpc Inc.
See all →- ModerateNew GPC Inc. Recalls Alcosulph Astringent Lotion for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Alcosulph Moisturizing Cream for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew Gpc Inc. Recalls Rector's Remedy Ointment for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Whitfield Lotion for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Ferrol Expectorant for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02